Soho Flordis International

Equazen® Baby

Providing essential fatty acid supplementation to help support brain growth and development in babies.*

Equazen® Baby

We know how important it is for us all to consume enough essential fatty acids to maintain a healthy mind and body, but these are especially important during the first two years of life when the brain develops most rapidly.

A developing baby will receive essential fatty acids through its mother’s placenta during pregnancy, and if breast-fed, during breast-feeding, or through infant formula. Following this stage, it is important that the growing baby obtains these essential fatty acids through their own diet.

To help support this, EQUAZEN baby formulation has been specifically formulated to provide specific omega-3 and omega-6 essential fatty acids for babies aged 6 months to 3 years*. Similar to the capsules of its parent product, EQUAZEN mumomega, the essential fatty acids in EQUAZEN baby are delivered in simple Twist-Off capsules. This allows easy administration of the contents into food or drink.

*Essential fatty acids (ALA) & (LA) are needed for normal growth and development of children. The beneficial effect is obtained with  a daily intake of 2g of alpha linolenic acid (ALA) and 10g of linoleic acid (LA).

30 twist off capsules

It’s important to consider Equazen® Baby because:

Brain growth <sup>1</sup>

Brain growth 1

The brain grows rapidly during the first 2 years of life where it becomes nearly 80% the size of the adult brain

The brain needs EFAs <sup>2</sup>

The brain needs EFAs 2

Approximately 60% of the brains’ weight consists of fats, of which about 30% are polyunsaturated fatty acids (such as EFAs)

Supports brain development

Supports brain development

Essential fatty acids (ALA) & (LA) are needed for normal growth and development of children.*'

Clinically Researched

Equazen® Baby: Key Ingredients

  • Omega-3 Dochosahexaenoic Acid (DHA) from fish oil provides the building blocks of the brain, nervous system and eyes** Particularly important during the third trimester of pregnancy and during the first two years of life, when the brain develops more rapidly.'
  • Omega-3 Eicosapentaenoic Acid (EPA) is one of the fatty acids that makes up Omega-3 found in oily fish
  • Omega-6 Gamma Linolenic Acid (GLA) from cold pressed evening primrose oil and metabolite Arachidonic Acid (AA),  ensures a synergistic and balanced formulation to meet the body’s individual needs.
More on essential fatty acids

Food for thought: Did you know that nutrition is the most influential non-genetic factor of brain development?

What makes Equazen® different?

Equazen contains only high quality ingredients. Our oil comes from sustainable fish sources such as sardines and anchovies from the Southern Pacific and Morocco Sea.

Follow the source to patient journey

Using Equazen® Baby

Recommended dosage & directions

Equazen® Baby twist cap: Suitable from 6 months to 3 years

Dose: Twist off capsule and squeeze into any food or drink once daily

 

Always follow the instructions for use provided on the label.

 

Safety

Equazen is well tolerated. Tolerability data from clinical investigations as well as the post-marketing experience confirm the safety profile of Equazen formulations.

Key ingredient
Essential fatty acids

Each twist cap contains:

DHA (docosahexaenoic acid) 100 mg
EPA (eicosapentaenoic acid)     14 mg
GLA (gamma-linolenic acid)       5 mg

Packaging and product claims may vary depending on country-specific regulations. Products are available in selected markets only.

*Essential fatty acids (ALA) & (LA) are needed for normal growth and development of children. The beneficial effect is obtained with a daily intake of 2g of alpha-linolenic acid (ALA) and 10g of linoleic acid (LA).

**DHA maternal intake contributes to normal development of the brain and eye of the foetus and breastfed infants. A daily intake of 200mg DHA is required in addition to the recommended daily intake of 250mg DHA & EPA for adults. 

This product provides 300mg DHA and 42mg EPA daily.  

References
1. Sinn N and Bryan J. J Dev Behav Pediatr. 2007;28(2):82-91.
2. Sinn N et al. Prostaglandins Leukot Essent Fatty Acids. 2008;78(4-5):311-26.
3. Richardson AJ et al. Pediatrics. 2005 May;115(5):1360-6.
4. Kidd PM. Altern Med Rev. 2007 Sep;12(3):207-27.
5. Simopoulos AP. World Nutr Diet. Basel,Karger,2003,vol92,pp1-22.
6. Innis SM. J Nutr. 2007 Apr;137(4):855-9.
7. Antalis CJ, et al. Prost leukot Essent Fatty Acids. 2006;75(4-5):299.
 

We use cookies to give you the best experience on our website. You can find out more about the cookies we use and how to change your settings.

I accept